文献速递浆细胞疾病

多发性骨髓瘤的诊断路径及其与终末器官损害的关系:基于TEAMM试验的分析

Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial.
PubMed 文献 · Br J Haematol · 2020-08-15

TEAMM试验纳入915例多发性骨髓瘤患者,评估诊断路径与诊断时间及疾病严重程度的关系。51%经初级保健直接转诊血液科,29%经急诊服务诊断,20%经其他二级专科转诊;经其他二级专科转诊者诊断间隔较长(中位120天 vs 59天)但无严重疾病特征增加,提示疾病相对惰性;经急诊服务诊断者体能状态更差(P<0·0001)且终末器官损害负担更高(P<0·0001),但诊断路径总长度与直接转诊无差异(中位59天)。

要点

  • 51%经初级保健直接转诊血液科,29%经急诊服务,20%经其他二级专科转诊。
  • 经其他二级专科转诊者诊断间隔中位120天 vs 直接转诊59天,无严重疾病特征增加。
  • 经急诊服务诊断者体能状态更差(P<0·0001)且终末器官损害负担更高(P<0·0001)。

核心结论

  • 经急诊服务诊断的多发性骨髓瘤患者晚期疾病主要反映疾病侵袭性,而非诊断路径延长。
  • 经其他二级专科转诊者诊断间隔较长但无严重疾病特征增加,提示疾病相对惰性。
  • 院内延迟明显,提示可能存在改进空间。

研究设计与样本

  • 基于Tackling Early Morbidity and Mortality in Myeloma(TEAMM)试验的分析,纳入915例多发性骨髓瘤患者,评估诊断路径、诊断时间与疾病严重程度的关系。

主要发现

  • 51%经初级保健直接转诊血液科诊断,29%经急诊服务诊断,20%经其他二级专科转诊诊断。
  • 经其他二级专科转诊者诊断间隔中位120天 vs 直接转诊59天,无严重疾病特征增加。
  • 经急诊服务诊断者体能状态更差(P<0·0001)且终末器官损害负担更高(P<0·0001)。
  • 经急诊服务诊断者与直接转诊者诊断路径总长度无差异(中位59天)。
  • 经急诊服务诊断者中四分之一报告从初次医院会诊到血液科评估超过30天。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple myeloma is associated with significant early morbidity and mortality, with considerable end organ damage often present at diagnosis. The Tackling EArly Morbidity and Mortality in Multiple Myeloma (TEAMM) trial was used to evaluate routes to diagnosis in patients with myeloma and the relationship between diagnostic pathways, time to diagnosis and disease severity. A total of 915 participants were included in the study. Fifty-one per cent were diagnosed by direct referral from primary care to haematology; 29% were diagnosed via acute services and 20% were referred via other secondary care specialties. Patients diagnosed via other secondary care specialties had a longer diagnostic interval (median 120 days vs. 59 days) without an increase in features of severe disease, suggesting they had a relatively indolent disease. Marked intrahospital delay suggests possible scope for improvement. A quarter of those diagnosed through acute services reported >30 days from initial hospital consultation to haematology assessment. Participants diagnosed through acute services had poorer performance status (P < 0·0001) and higher burden of end organ damage (P < 0·0001) with no difference in the overall length of diagnostic pathway compared to those diagnosed by direct referral (median 59 days). This suggests that advanced disease in patients presenting through acute services predominantly reflects disease aggression.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Atkin C, Iqbal G, Planche T, et al. Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial. Br J Haematol. 2020. PMID: 32798327. doi:10.1111/bjh.17044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。